Correlation Between State Trading and Beta Drugs
Specify exactly 2 symbols:
By analyzing existing cross correlation between The State Trading and Beta Drugs, you can compare the effects of market volatilities on State Trading and Beta Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in State Trading with a short position of Beta Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of State Trading and Beta Drugs.
Diversification Opportunities for State Trading and Beta Drugs
-0.17 | Correlation Coefficient |
Good diversification
The 3 months correlation between State and Beta is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding The State Trading and Beta Drugs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Beta Drugs and State Trading is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on The State Trading are associated (or correlated) with Beta Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Beta Drugs has no effect on the direction of State Trading i.e., State Trading and Beta Drugs go up and down completely randomly.
Pair Corralation between State Trading and Beta Drugs
Assuming the 90 days trading horizon The State Trading is expected to under-perform the Beta Drugs. In addition to that, State Trading is 1.14 times more volatile than Beta Drugs. It trades about -0.06 of its total potential returns per unit of risk. Beta Drugs is currently generating about 0.11 per unit of volatility. If you would invest 169,995 in Beta Drugs on September 22, 2024 and sell it today you would earn a total of 36,010 from holding Beta Drugs or generate 21.18% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 98.41% |
Values | Daily Returns |
The State Trading vs. Beta Drugs
Performance |
Timeline |
State Trading |
Beta Drugs |
State Trading and Beta Drugs Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with State Trading and Beta Drugs
The main advantage of trading using opposite State Trading and Beta Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if State Trading position performs unexpectedly, Beta Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Beta Drugs will offset losses from the drop in Beta Drugs' long position.State Trading vs. Yes Bank Limited | State Trading vs. Kingfa Science Technology | State Trading vs. Rico Auto Industries | State Trading vs. GACM Technologies Limited |
Beta Drugs vs. Nahar Industrial Enterprises | Beta Drugs vs. ILFS Investment Managers | Beta Drugs vs. The State Trading | Beta Drugs vs. Indian Metals Ferro |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Money Managers Screen money managers from public funds and ETFs managed around the world |